CD86 (Dendritic Cells Maturation Marker) Antibody

SKU: orb388891

Description

Mouse monoclonal antibody to CD86

Research Area

Product Categories/Products/Antibodies/Primary Antibodies,Infectious Diseases,Immunology,Product Categories/Antibodies,Product Categories/Products/Antibodies,Epigenetics,B Cell Markers|Cardiovascular|Cytokine Signaling|Dendritic Cell Marker|Hematopoietic Stem Cells|Immuno Oncology|Immunology|Infectious Disease|Signal Transduction

Images & Validation

• Tested Applications: IF, IHC, WB
• Dilution Range: FACS: 0.5-1 μg/million cells, IF/ICC: 0.5-1 μg/ml, WB: 0.5-1 μg/ml, IHC-P: 2-4 μg/ml
• Reactivity: Human, Mouse, Rat
• Application Notes:
  CD86 (Dendritic Cells Maturation Marker)

Key Properties

• Host: Mouse
• Clonality: Monoclonal
• Isotype: IgG1
• Clone No.: C86/1146
• Immunogen: Recombinant human full-length CD86 protein
• Target: CD86
• Source/Expression System: Bioreactor
• Molecular Weight: 70kDa
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% rAlbumin & 0.05% azide. Also available WITHOUT rAlbumin & azide at 1.0mg/ml.
• Buffer/Preservatives: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% rAlbumin & 0.05% azide. Also available WITHOUT rAlbumin & azide at 1.0mg/ml.
• Concentration: Purified Ab with BSA and Azide at 200ug/ml
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Activation B7-2 antigen; B lymphocyte activation antigen B72; CD28 antigen ligand 2; CD28LG2; CLS1; CTLA-4 counter-receptor B7.2; Early T-cell co-stimulatory molecule 1; ETC-1; FUN-1; LAB72; Ly-58; MB7-2; TS/A-2

Quick Database Links

Gene Symbol

CD86

UniProt

P42081

NCBI Gene ID

942

Yu X., Xu L., Zhou Y., Zhou X, Yang L., Zhou Y. NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma Dove Medical Press, 16, 3799-3809 (2023)

PubMed: